Health
As variants threaten Covid-19 progress, US weighs trial results of Johnson & Johnson vaccine candidate – CNN International
As worrisome Covid-19 variants are increasingly found in the United States, experts say Johnson & Johnson’s vaccine candidate would help in the pandemic fight,…
(CNN)As worrisome Covid-19 variants are increasingly found in the United States, experts say Johnson & Johnson’s vaccine candidate would help in the pandemic fight, despite trial reports showing apparently lower efficacy rates than two vaccines already authorized in the US.
Johnson & Johnson’s single-shot coronavirus vaccine was shown to be 66% effective in preventing moderate and severe disease in a global Phase 3 trial and 85% effective against severe disease, the company announced Friday. It…
-
General19 hours agoVictorian school teacher charged with soliciting child abuse material
-
General10 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Business14 hours agoUp 20% in 2 days, are Codan shares a buy, hold or sell?
-
Business22 hours agoEconomic roundtable or maturity test?